CUDC-907

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta ; Homo sapiens







5 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33392641 Antitumor activity and mechanism of resistance of the novel HDAC and PI3K dual inhibitor CUDC-907 in pancreatic cancer. 2021 Mar 1
2 32200503 CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cells. 2020 Dec 1
3 30224636 CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression. 2019 May 1
4 28819699 CUDC-907, a dual HDAC and PI3K inhibitor, reverses platinum drug resistance. 2018 Feb 1
5 26796063 Human ATP-Binding Cassette Transporter ABCG2 Confers Resistance to CUDC-907, a Dual Inhibitor of Histone Deacetylase and Phosphatidylinositol 3-Kinase. 2016 Mar 7 2